Skip to content
Create account to build your panelHelp me choose

What your luteal phase is actually trying to tell you

By the EllaDx team · Updated November 1, 2026 · 8 min read

For education only, not a diagnosis. Talk to your clinician about your results.

Woman with braids asleep on a green pillow
← Back to Journal

The second half of your menstrual cycle - the luteal phase - runs from ovulation to your next period. A progesterone blood test in this phase can help answer one clear question: did you ovulate? It can't do much more on its own, and the timing has to be right.

The first half, the follicular phase, runs from day 1 to ovulation. It's the part of the cycle that varies most (Fehring et al., 2006). The luteal phase isn't a window on perimenopause in the way you may have read. Classic studies found that the first detectable hormone change in that transition is in FSH, while cycles stay regular (Hale et al., 2009). A large study of women aged 43 to 53 found a small but detectable decrease in luteal progesterone as they moved through the transition (Santoro et al., 2008). And no specific hormone marker can stage the transition (Burger et al., 2008).

Why timing matters

After ovulation, the collapsed follicle becomes the corpus luteum, a temporary gland that makes progesterone. In one study, progesterone began to climb only after ovulation, and that climb can help confirm ovulation happened (Roos et al., 2015). The luteal phase averaged about 14 days in one study (Lenton et al., 1984), and a reference study set the mid-luteal phase at 5 to 9 days after the LH peak (Stricker et al., 2006). In a 28-day cycle with ovulation around day 14, that falls near day 21. Levels can vary widely between cycles and between women (Stricker et al., 2006), and labs and guidelines differ in how they read them. Studies have used these cutoffs, which can't diagnose anything on their own:

  • A study of conception cycles in people being seen for infertility proposed 9.4 ng/mL as a mid-luteal lower limit for a potentially fertile cycle (Hull et al., 1982).
  • A population study counted a luteal level of at least about 3 ng/mL as ovulation, so a level under that may point to a cycle without ovulation (Prior et al., 2015).
  • Levels in between are harder to read. One older study proposed a 'defective luteal phase' range from a single sample (Wathen et al., 1984), but how to diagnose luteal problems remains controversial (ASRM Practice Committee, 2026).
Timing matters as much as the number
Progesterone can climb after ovulation, not before, so a level drawn before ovulation can't confirm it. In one study, ovulation ranged from day 8 to day 26 (Roos et al., 2015). That's why the draw is aimed at about a week after your own ovulation, not at a calendar date.

Three patterns you may hear about

Each of these has a different level of evidence behind it.

1. Silent anovulation

Your cycle can look regular without ovulation happening every time. In a Norwegian study of women with normal-length cycles, about 37% of those with a blood test in the luteal window had no sign of ovulation in that cycle (Prior et al., 2015). That study used one test in one cycle, so it can't say what happens in other months. Women with and without ovulation did not differ in age, so that study can't tie it to early perimenopause. Anovulatory cycles can become more frequent as the transition goes on. One review placed the increase in the last 30 months before the final period (Burger et al., 2008). A large study of women aged 43 to 53 found that cycles that looked ovulatory fell from about 81% to 65% by its third yearly check (Santoro et al., 2008). A progesterone result can't explain new anxiety or trouble sleeping on its own, so see a clinician about them.

2. Short luteal phase

Here, ovulation happens but the luteal phase is short. An American Society for Reproductive Medicine committee ties luteal phase deficiency to a luteal phase of 10 days or fewer, and says causes can include progesterone that doesn't last long enough or doesn't reach adequate levels (ASRM Practice Committee, 2026). In a study of 259 regularly menstruating women, about 9% of ovulatory cycles had a short luteal phase (Schliep et al., 2014). The same committee says this hasn't been proven to be an independent cause of infertility or recurrent pregnancy loss (ASRM Practice Committee, 2026). A single blood draw can't measure how long a phase lasts. If you've had a pregnancy loss or are having trouble getting pregnant, talk to a clinician.

3. 'Estrogen dominance'

You may see this term online for estrogen that stays high in the luteal phase while progesterone lags. It isn't an established diagnosis, and we found no guideline that defines it or sets a ratio to test for it. A small urine study of 11 women around perimenopause found higher estrogen breakdown products and lower luteal progesterone breakdown products than in younger women (Santoro et al., 1996). But hormones in the transition can be erratic and unpredictable (Burger et al., 2008). In regularly menstruating women, cycles with a short luteal phase or low luteal progesterone were found to have lower estradiol, not higher (Schliep et al., 2014).

Symptoms before a period don't fit a simple ratio either. In a study of women with menstrually related mood symptoms, progesterone and estradiol levels and patterns did not differ from those of controls (Rubinow et al., 1988). A recent review of premenstrual dysphoric disorder (PMDD) describes a difference in sensitivity to allopregnanolone, a steroid made from progesterone (Bixo et al., 2026).

Tender breasts, headaches before your period and mood changes can have many causes, so talk to a clinician about them. See a clinician about heavy periods too. If your mood has been down, get help now. Treatment doesn't need to wait for a lab test.

What to ask for

If you're trying to get pregnant or your periods are irregular, ask a clinician whether a progesterone test timed to ovulation would help, and when to draw it. If your periods have stopped, see a clinician to find out why. One study concluded that identifying ovulation and adding a well-timed progesterone level may be a useful way to assess luteal phase deficiency (Schliep et al., 2014). Testing has limits, though. There's controversy over how to diagnose luteal phase deficiency and, even if it can be diagnosed, whether treatment improves outcomes (ASRM Practice Committee, 2026).

Tracking can help with the timing, because a generic 'day 21' can miss the window in a long cycle. In urine, the start of the LH surge was an excellent predictor of ovulation in one study (Roos et al., 2015). Basal body temperature is less exact: specialists reading charts were reliably accurate only to within two or three days of the LH surge (Quagliarello et al., 1986). Ask your clinician how to time the draw.

References

  • Wathen, N. C., et al. (1984). Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. British Medical Journal, 288(6410), 7-9. PMID 6418326
  • Hull, M. G., et al. (1982). The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles. Fertility and Sterility, 37(3), 355-360. PMID 7060786
  • Prior, J. C., et al. (2015). Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles - A Population-Based Cohort from HUNT3, Norway. PLOS One, 10(8), e0134473. PMID 26291617
  • Roos, J., et al. (2015). Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation. European Journal of Contraception and Reproductive Health Care, 20(6), 438-450. PMID 26018113
  • Fehring, R. J., et al. (2006). Variability in the phases of the menstrual cycle. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 35(3), 376-384. PMID 16700687
  • Hale, G. E., et al. (2009). Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause. Best Practice & Research Clinical Obstetrics & Gynaecology, 23(1), 7-23. PMID 19046657
  • Santoro, N., et al. (2008). Factors related to declining luteal function in women during the menopausal transition. Journal of Clinical Endocrinology & Metabolism, 93(5), 1711-1721. PMID 18285413
  • Burger, H. G., et al. (2008). Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause, 15(4 Pt 1), 603-612. PMID 18574431
  • Lenton, E. A., et al. (1984). Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. British Journal of Obstetrics and Gynaecology, 91(7), 685-689. PMID 6743610
  • Stricker, R., et al. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clinical Chemistry and Laboratory Medicine, 44(7), 883-887. PMID 16776638
  • Practice Committee of the American Society for Reproductive Medicine. (2026). Diagnosis and treatment of luteal phase deficiency: a Committee Opinion. Fertility and Sterility, 126(4), 633-639. PMID 42414147
  • Schliep, K. C., et al. (2014). Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. Journal of Clinical Endocrinology & Metabolism, 99(6), E1007-14. PMID 24606080
  • Santoro, N., et al. (1996). Characterization of reproductive hormonal dynamics in the perimenopause. Journal of Clinical Endocrinology & Metabolism, 81(4), 1495-1501. PMID 8636357
  • Rubinow, D. R., et al. (1988). Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology, 158(1), 5-11. PMID 2962499
  • Bixo, M., et al. (2026). Neurosteroids and premenstrual dysphoric disorder. British Journal of Psychiatry, 229(1), 92-100. PMID 40518728
  • Quagliarello, J., et al. (1986). Inaccuracy of basal body temperature charts in predicting urinary luteinizing hormone surges. Fertility and Sterility, 45(3), 334-337. PMID 3949032